DHR
Danaher Corporation · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers):
breedte van houders +4.5% ·
aandelenstroom +0.4% ·
netto nieuwe posities +4.3%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 190 | +7 | 438.01M | $83.49B | +10 | −2 |
| Q1 2026 | 185 | -2 | 440.89M | $83.51B | +5 | −8 |
| Q4 2025 | 186 | -1 | 467.58M | $107.03B | +2 | −2 |
| Q3 2025 | 30 | -1 | 269.80M | $53.47B | +1 | −3 |
| Q2 2025 | 29 | +2 | 237.37M | $46.89B | +3 | −1 |
| Q1 2025 | 24 | -1 | 116.89M | $23.96B | +1 | −2 |
| Q4 2024 | 25 | +1 | 111.55M | $25.60B | +1 | — |
| Q3 2024 | 23 | +1 | 81.67M | $22.69B | +2 | −1 |
| Q2 2024 | 22 | — | 81.37M | $20.32B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 23.31M | -4.8% | $6.48B | 1.1% | ▼ Trim | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 20.47M | +5.6% | $5.69B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 20.47M | +5.6% | $5.69B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 13.04M | -1.1% | $3.61B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 13.04M | -1.1% | $3.61B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 14 | Norges Bank ✦ (passief) | 8.95M | -2.4% | $2.49B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 15 | Capital World Investors ✦ | 4.79M | +0.5% | $1.33B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 4.55M | +2.6% | $1.27B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 17 | Third Point ✦ | 1.95M | -4.9% | $542.14M | 7.3% | ▼ Trim | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 1.10M | -42.6% | $304.55M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 1.10M | -42.6% | $304.55M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 1.10M | -42.6% | $304.55M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 671.39K | +54662.3% | $186.66M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 671.39K | +54662.3% | $186.66M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 665.08K | -14.5% | $184.91M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 24 | Millennium Management ✦ | 495.18K | +332.4% | $137.67M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 25 | Gates Foundation Trust ✦ | 373.00K | 0.0% | $103.70M | 0.2% | Held | 2 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 361.37K | +19.1% | $99.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 361.37K | +19.1% | $99.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 361.37K | +19.1% | $99.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 361.37K | +19.1% | $99.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 30 | Arrowstreet Capital ✦ | 334.06K | +278.5% | $92.88M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 246.56K | Nieuw | $68.55M | 0.2% | New | 1 | SEC ↗ |
| 32 | Point72 Asset Management ✦ | 239.95K | Nieuw | $66.71M | 0.2% | New | 1 | SEC ↗ |
| 33 | Gotham Asset Management ✦ | 44.22K | +3.7% | $12.29M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 34 | PRIMECAP Management ✦ | 31.94K | -52.3% | $8.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | Harris Associates (Oakmark) ✦ | 18.92K | -73.8% | $5.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | Dodge & Cox ✦ | 16.52K | 0.0% | $4.59M | 0.0% | Held | 2 | SEC ↗ |
| 37 | D. E. Shaw & Co. ✦ | 5.15K | +90.7% | $1.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | D. E. Shaw & Co. ✦ | 5.15K | +90.7% | $1.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | GAMCO Investors ✦ | 3.12K | +39.4% | $866,588 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Bridgewater Associates ✦ | 1.68K | -6.5% | $467,074 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Two Sigma Investments | $68.55M | 0.2% |
| Point72 Asset Management | $66.71M | 0.2% |
Verlaten
| Soros Fund Management | $29.98M | was 0.9% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 2,147 houders, 548.39M aandelen, $97.77B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 11.31K aand · $2.46M
Officer, Director · 39.19K aand · $8.57M
Officer, Director · 7.75K aand · $1.70M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie